BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs, and unconventional partnerships.This is not a conference about the distant future. It's a working summit for what can be done now. It's about survival,…
Shots:Clinical-stage biopharma companies are in constant need of funding and the best way to pull in money in such dire situations is by going public. 2023 had been a great year for Wall Streets across the globe with continuous announcements of IPOsKenvue by bagging $4.37B upon completion of its IPO ranked first in…
Shots:In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and HealthcareIn 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…
Shots:The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industryIn February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative ColitisPharmaShots has compiled a list of a total…
Shots: Know Your Investor is an earnest effort from PharmaShots to acquaint our readers with leading Investors and venture capital firms in the healthcare industry Founded in 1969, F-Prime Capital Partners is a subsidiary of Fidelity Investments and primarily invests in healthcare and technology A total of 40 investments were closed by F-Prime in 2023,…
Shots: New Year, New Us! Our hand-curated “Know Your Investor” reports will now be exploring leading investors of 2023 Founded in 2002, RA Capital forged ahead to become a key investor in life science and healthcare companies. In 2023, RA Capital closed 40 major investments in biopharma companies, devices, manufacturing, service offering firms, and diagnostics …
Shots:Know Your Investor’s November Edition revolves around Alexandria Venture Investments, which dedicatedly invests in the healthcare sector Established in 1996, Alexandria Venture Investments is based in Pasadena, California, and is the corporate venture capital arm of Alexandria Real Estate EquitiesIn 2022, Alexandria participated in 31 investment rounds, with Affini-T Therapeutics receiving the highest…
Shots: Know Your Investor’s October Edition focuses on a renowned healthcare investment firm, OrbiMed Advisors, known for making considerable investments in healthcare companies In 1989, Viren Mehta and Samuel Isaly founded a money management and research organization, an antecedent to OrbiMed. The company made its first investment in 1993 In 2022, OrbiMed Advisors made 31…
Shots:PharmaShots' tertiary report on the Know Your Investor Section features F-Prime Capital Partners. Know Your Investor is an earnest effort from PharmaShots to acquaint our readers with leading Investors and venture capital firms in the healthcare industryFounded in 1969, F-Prime Capital Partners is a subsidiary of Fidelity Investments and primarily invests in healthcare…
Shots:PharmaShots’ second dose of the Know Your Investor series focuses on RA Capital Management LLC. Know Your Investor is an earnest effort from PharmaShots to acquaint our readers with leading Investors and venture capital firms in the healthcare industryFounded in 2002, RA Capital forged ahead to become a key investor in life science…

